Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | -2.40% | +0.93% | +115.23% |
04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+115.23% | 875M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment